The estimated Net Worth of Robert A Lippe is at least $2.93 Millón dollars as of 30 November 2023. Mr. Lippe owns over 1,718 units of Liquidia Corp stock worth over $1,971,993 and over the last 6 years he sold LQDA stock worth over $0. In addition, he makes $954,381 as Chief Operations Officer at Liquidia Corp.
Robert has made over 7 trades of the Liquidia Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 1,718 units of LQDA stock worth $17,438 on 30 November 2023.
The largest trade he's ever made was exercising 51,250 units of Liquidia Corp stock on 10 November 2021 worth over $520,188. On average, Robert trades about 6,773 units every 54 days since 2019. As of 30 November 2023 he still owns at least 194,285 units of Liquidia Corp stock.
You can see the complete history of Mr. Lippe stock trades at the bottom of the page.
Robert A. Lippe serves as Chief Operations Officer of the Company. Mr. Lippe served as executive vice president of operations and chief operations officer at Alexza Pharmaceuticals, Inc. From January 2011 to February 2014, Mr. Lippe worked as the head of global operations at Ironwood Pharmaceuticals, Inc., and from March 2002 to January 2011, he was the head of manufacturing for one of Genentech, Inc.'s Vacaville operating facilities. From May 1992 to May 2002, Mr. Lippe worked at Lawrence Livermore National Laboratory as an assurance and facility manager. Mr. Lippe graduated with a Bachelor of Science in Marine Engineering from the United States Coast Guard Academy. Mr. Lippe holds a Master of Business Administration and Public Health from the University of California, Berkeley.
As the Chief Operations Officer of Liquidia Corp, the total compensation of Robert Lippe at Liquidia Corp is $954,381. There are 1 executives at Liquidia Corp getting paid more, with Neal Fowler having the highest compensation of $1,729,090.
Robert Lippe is 55, he's been the Chief Operations Officer of Liquidia Corp since 2015. There are 12 older and 8 younger executives at Liquidia Corp. The oldest executive at Liquidia Corp is Ralph Snyderman, 80, who is the Independent Director.
Robert's mailing address filed with the SEC is 419 DAVIS DRIVE, SUITE 100, , MORRISVILLE, NC, 27560.
Over the last 6 years, insiders at Liquidia Corp have traded over $16,750,945 worth of Liquidia Corp stock and bought 12,456,625 units worth $100,694,400 . The most active insiders traders include Forest Baskett, Scott D Sandell y Peter J Barris. On average, Liquidia Corp executives and independent directors trade stock every 18 days with the average trade being worth of $1,467,274. The most recent stock trade was executed by Russell Schundler on 30 August 2024, trading 2,344 units of LQDA stock currently worth $23,792.
liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.
Liquidia Corp executives and other stock owners filed with the SEC include: